SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-004163
Filing Date
2017-03-09
Accepted
2017-03-09 16:06:20
Documents
17
Period of Report
2017-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170308_8k.htm 8-K 27875
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 201382
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 5800
4 a12.jpg GRAPHIC 47817
5 a11.jpg GRAPHIC 86796
6 a10.jpg GRAPHIC 171360
7 a9.jpg GRAPHIC 143162
8 a8.jpg GRAPHIC 111248
9 a7.jpg GRAPHIC 141146
10 a6.jpg GRAPHIC 120448
11 a5.jpg GRAPHIC 131836
12 a4.jpg GRAPHIC 93632
13 a3.jpg GRAPHIC 48565
14 a2.jpg GRAPHIC 272002
15 a1.jpg GRAPHIC 47817
16 ex99-1img002.jpg GRAPHIC 3740
17 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-004163.txt   2195536
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 17678333
SIC: 2834 Pharmaceutical Preparations